The Effect of Acarbose on Insulin Sensitivity in Subjects With Impaired Glucose Tolerance (original) (raw)

Diabetes Care, 2000

Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance

JAMA, 2003

Low-dose acarbose improves glycemic control in NIDDM patients without changes in insulin sensitivity

Kerin Odea, Alison Nankervis

Diabetes Care, 1993

Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose

Wim de Grauw

Protocols, 1996

Acarbose: its role in the treatment of diabetes mellitus

Lance Campbell

The Annals of …, 1996

Acarbose in the treatment of elderly patients with type 2 diabetes

Diabetes Research and Clinical Practice, 2003

Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects

Mary Joy Mortiz Deleon

Diabetes Research and Clinical Practice, 2002

The STOP-NIDDM Trial: An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data

Diabetes Care, 1998

Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus

Current Opinion in Pharmacology, 2005

Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes

ramesh kumar tanwani

JPMA. The Journal of …, 2000

Acarbose for the Prevention of Diabetes, Hypertension, and Cardiovascular Disease in Subjects with Impaired Glucose Tolerance: The Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (Stop-Niddm) Trial

Endocrine Practice, 2006

Acarbose improves glycemic control as add-on or monotherapy in Indian type-2 diabetes: Findings from the GlucoVIP multinational observational study

Rupam Kumar Das

Indian Journal of Endocrinology and Metabolism, 2013

Acute effects of acarbose on post-prandial glucose and triglycerides in type 2 diabetics following intake of different Malaysian foods

Hapizah Nawawi

Asia Pacific Journal of Clinical Nutrition, 2000

Long-term efficacy and tolerability of acarbose treatment in patients with type 2 diabetes mellitus

Andreas Brückner

Clinical drug …, 2005

Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients

H. Rietzsch

Diabetes, Obesity and Metabolism, 2003

Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes

Ji-hyun Kim

Journal of Diabetes Investigation, 2014

A Multinational, Observational Study to Investigate the Efficacy, Safety and Tolerability of Acarbose as Add-On or Monotherapy in a Range of Patients: The GlucoVIP Study

Zahid Miyan

Clinical Drug Investigation, 2013

New horizons in diabetes therapy--alpha glucosidase inhibitors

Fatema Jawad

PubMed, 1994

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

The Lancet, 2002

-Glucosidase Inhibitors for Patients With Type 2 Diabetes: Results from a Cochrane systematic review and meta-analysis

Floris Laar

Diabetes Care, 2005

Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents α-Glucosidase inhibitors and their use in clinical practice

Sibel Ertek

Archives of Medical Science, 2012

Beneficial effects of dietary acarbose in the streptozotocin-induced diabetic rat

Joseph Vasselli

Metabolism, 1991

No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate

Diabetes Care, 1998

Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 1997

The beneficial effect of α-glucosidase inhibitor on glucose variability compared with sulfonylurea in Taiwanese type 2 diabetic patients inadequately controlled with metformin: preliminary data

Shih-Li Su

Journal of Diabetes and its Complications, 2011

Successful use of acarbose to manage post prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion

Satya Dash

Diabetes Research and Clinical Practice

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

Diabetologia, 2004

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Eberhard Standl

The Lancet Diabetes & Endocrinology, 2017